First regulatory approvals for CRISPR-Cas9 therapeutic gene editing for sickle cell disease and transfusion-dependent -Thalassemia
However, reimbursement depends on medical necessity, documentation quality, payer policies, and NCCI edit compliance
Heres a chart from the Ipsos report on 3 healthcare organizations growing their own consumer-facing chops including Abbott (which Ive seen annually for a few years at CES, expanding its presence and reputation as a consumer tech company
At Ro, you can get a vial of Zepbound via Eli Lillys own telehealth platform, LillyDirect
Patients should verify current program pricing directly at directmeds.com as promotional pricing and program structures are subject to change
10.1007/s00428-009-0858-z Virchows Arch